The first panoramic view of infection pathways in the human placenta has been created, which could highlight potential drug targets to develop pregnancy-safe therapies for malaria, toxoplasmosis and listeria, all diseases ...
6 hours ago
0
2
A study by scientists at the University of Oxford, has unveiled crucial insights into the way that COVID-19 vaccines mitigate severe illness in those who have been vaccinated.
7 hours ago
0
12
An article published in The FASEB Journal describes a Brazilian study analyzing the correlation between two key energy metabolism regulation processes: the absorption and release of calcium ions by mitochondria, the organelles ...
May 2, 2024
0
23
A University of California, Irvine-led team has found evidence of a potential link between patterns of changes in a key pregnancy hormone—placental corticotropin-releasing hormone—and symptoms of postpartum depression.
May 2, 2024
0
0
On May 1, Manatee County was set to launch a new pilot program that uses a drone to deliver a defibrillator, a tourniquet, or naloxone—an opioid-overdose antidote—to emergency scenes. The program is meant to reduce response ...
May 2, 2024
0
0
Duke researchers have opened a new avenue in the attack against influenza viruses by creating a vaccine that encourages the immune system to target a portion of the virus surface that is less variable.
May 1, 2024
0
6
Preoperative Botox injections are a useful test for predicting how well patients with chronic migraine will respond to nerve decompression surgery, reports a study in the May issue of Plastic and Reconstructive Surgery.
May 1, 2024
0
2
The brain can direct the immune system to an unexpected degree, capable of detecting, ramping up and tamping down inflammation, shows a new study in mice from researchers at Columbia's Zuckerman Institute.
May 1, 2024
0
13
An individual's experience of pain from medical treatment can be heightened by witnessing other people's responses to the same treatment, with this negative experience subsequently spreading to others, scientists have discovered.
Apr 30, 2024
0
31
There is no risk for new-onset seizure incidence for individuals receiving a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine versus placebo, according to a review published online April 29 in JAMA Neurology.
Apr 30, 2024
0
0
